Evidence map›Paper›PMID 36252184›Full record

ArticleAmerican journal of respiratory cell and molecular biology2023

Jason Hong, Brenda Wong, Caroline Huynh, Brian Tang, Gregoire Ruffenach, Min Li, Soban Umar, Xia Yang, Mansoureh Eghbali

Open access · greenAbstract read
In one paragraph

Article in American journal of respiratory cell and molecular biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.8field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Lung endothelial cell heterogeneity in health and pulmonary vascular disease.American journal of physiology. Lung cellular and molecular physiology · 2025
    Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Jason HongDivision of Pulmonary and Critical Care Medicine.
Brenda WongDivision of Pulmonary and Critical Care Medicine.
Caroline HuynhDepartment of Integrative Biology and Physiology, and.
Brian TangDepartment of Integrative Biology and Physiology, and.
Gregoire RuffenachDepartment of Anesthesiology and Perioperative Medicine, University of California, Los Angeles, Los Angeles, California.
Min LiDepartment of Anesthesiology and Perioperative Medicine, University of California, Los Angeles, Los Angeles, California.
Soban UmarDepartment of Anesthesiology and Perioperative Medicine, University of California, Los Angeles, Los Angeles, California.ORCID 0000-0001-8036-3079
Xia YangDepartment of Integrative Biology and Physiology, and.
Mansoureh EghbaliDepartment of Anesthesiology and Perioperative Medicine, University of California, Los Angeles, Los Angeles, California.
University of California, Los Angeles · USLaboratoire d’immunologie intégrative du cancer · FRPulmonary and Critical Care Associates · US

Funding

Role of intestinal inflammation in oxidized lipid induced pulmonary hypertensionR01HL162124 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI EGHBALI, MANSOUREH, REDDY, SRINIVASA T. · 2022 to 2025
$2.4M
Investigating the molecular mechanisms of right ventricular failure in pulmonary hypertensionR01HL161038 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Soban Umar · 2022 to 2026
$1.9M
Role of Chromosome Y gene, Uty, in protecting against Pulmonary HypertensionR01HL159865 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI EGHBALI, MANSOUREH · 2021 to 2024
$1.9M
Role of the Novel MicroRNA-125b in Pulmonary Hypertension Associated with Pulmonary FibrosisK08HL141995 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI UMAR, SOBAN · 2019 to 2023
$879k
NHLBI NIH HHS K08 HL141995NHLBI NIH HHS R01 HL159865NHLBI NIH HHS R01 HL161038NHLBI NIH HHS R01 HL162124
6 · The paper itself

Abstract

The identification and role of endothelial progenitor cells in pulmonary arterial hypertension (PAH) remain controversial. Single-cell omics analysis can shed light on endothelial progenitor cells and their potential contribution to PAH pathobiology. We aim to identify endothelial cells that may have stem/progenitor potential in rat lungs and assess their relevance to PAH. Differential expression, gene set enrichment, cell-cell communication, and trajectory reconstruction analyses were performed on lung endothelial cells from single-cell RNA sequencing of Sugen-hypoxia, monocrotaline, and control rats. Relevance to human PAH was assessed in multiple independent blood and lung transcriptomic data sets. Rat lung endothelial cells were visualized by immunofluorescence

Indexed as

Endothelial Progenitor CellsPulmonary Arterial HypertensionAnimalsAntigens, SurfaceDisease Models, AnimalEndotheliumFamilial Primary Pulmonary HypertensionHumansMembrane ProteinsMonocrotalineNeoplasm ProteinsPulmonary ArteryRatsAntigens, SurfaceMembrane ProteinsMonocrotalineNeoplasm ProteinsTM4SF1 protein, humanTm4sf1 protein, ratendothelial progenitor cellsmonocrotalinepulmonary hypertensionsingle-cell RNA sequencingSugen–hypoxia

Identifiers

PMID36252184
PMCPMC10112423
OpenAlexW4306641114

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.